Michelle Gill, MD, PhD  m.gill@wustl.edu

Profile picture
Professor of Pediatrics, Allergy, Immunology and Pulmonary Medicine
Allergy, Immunology and Pulmonary Medicine

phone: (314) 454-2694

Education

  • BS, Louisiana State University1988
  • PhD, Louisiana State University Medical Center1993
  • MD, Louisiana State University Medical Center1995

Training

  • Residency, Pediatric Internship; Residency, Chief, University of Arkansas for Sciences1995 - 1998
  • Fellowship, Pediatric Infectious Diseases, UT Southwestern Medical Center1999 - 2003

Licensure and Board Certification

  • 1993 - 1996USMLE, Parts I, II, and III
  • 1996 - 1999Arkansas State Medical Board
  • 1998American Academy of Pediatrics, Pediatrics Certification
  • 2003American Academy of Pediatrics, Pediatric Infectious Diseases Certification, recertification 2013
  • 2003 - PresTexas State Medical Board
  • 2007Maintenance of Pediatrics Board Certification Exam
  • 2021Missouri State Medical License (pending)

Honors and Awards

  • LSU-S Academic Scholarship, Omicron Delta Kappa, Honor Society, Louisiana State University in Shreveport, Shreveport, LA1985 - 1988
  • Doctor-Patient Relationship Award, Shreveport Medical Society1995
  • Debra H. Fiser Award for Excellence in Critical Care, University of Arkansas for Medical Sciences, Little Rock, AR1998
  • Donald E. Hill Memorial Award for Excellence in Research, University of Arkansas for Medical Sciences, Little Rock, AR1998
  • Pediatric Research Fellowship Award, $90k (peer-reviewed competitive award for fellowship funding), Pediatric Infectious Diseases Society2000 - 2002
  • Research Grant Awards, Children’s Medical Center Foundation (2002, 2003)2002
  • Outstanding Teacher. Award from Medical Student Class of 2010, UT Southwestern Medical Center-Dallas, TX2007 - 2008
  • Best Pediatric Specialists/Doctors in Dallas, D Magazine, Dallas, Texas. (2010, 2013, 2018, 2019)2010
  • Research Mentor Award, CMC-Dallas Pediatric Residency training program2013

Recent Publications view all (54)


Publication Co-Authors

  1. Development of nasal allergen challenge with cockroach in children with asthma. Pediatr Allergy Immunol. 2021;32(5):971-979. PMID:33606312 
  2. Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children. J Allergy Clin Immunol. 2021. PMID:34019912 
  3. IgE-mediated regulation of IL-10 and type I IFN enhances rhinovirus-induced Th2 differentiation by primary human monocytes. Eur J Immunol. 2020;50(10):1550-1559. PMID:32383224 
  4. Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma. J Allergy Clin Immunol Pract. 2020;8(9):3021-3028.e2. PMID:32376491 
  5. Serum IL-6: A biomarker in childhood asthma? J Allergy Clin Immunol. 2020;145(6):1701-1704.e3. PMCID:PMC7282967  PMID:32004524 
  6. Type I interferon suppresses memory Th2 cell cytokine secretion from allergic subjects. Allergy. 2020;75(3):695-698. PMID:31541610 
  7. Regulation of allergic inflammation by dendritic cells. Curr Opin Allergy Clin Immunol. 2020;20(1):56-63. PMID:31789871 
  8. Development of Palladium-Catalyzed Decarboxylative Allylation of Electron-Deficient Sulfones and Identification of Unusual Side Products. J Org Chem. 2019;84(10):6028-6039. PMID:30964285 
  9. Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children. Nat Immunol. 2019;20(5):637-651. PMCID:PMC6472965  PMID:30962590 
  10. Expression of corticosteroid-regulated genes by PBMCs in children with asthma. J Allergy Clin Immunol. 2019;143(3):940-947.e6. PMCID:PMC8210855  PMID:30059697 
  11. Targeting Antiviral Pathways for Treatment of Allergic Diseases. J Pediatric Infect Dis Soc. 2018;7(suppl_2):S54-S56. PMID:30590620 
  12. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol. 2018;141(5):1735-1743.e9. PMCID:PMC6013066  PMID:28870461 
  13. Adrenergic Signaling at the Interface of Allergic Asthma and Viral Infections. Front Immunol. 2018;9:736. PMCID:PMC5904268  PMID:29696025 
  14. Perspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine. Pediatr Res. 2018;83(1-1):31-40. PMID:28945700 
  15. Endotypes of difficult-to-control asthma in inner-city African American children. PLoS One. 2017;12(7):e0180778. PMCID:PMC5501607  PMID:28686637 
  16. IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation. J Allergy Clin Immunol. 2017;140(1):294-298.e8. PMCID:PMC5794014  PMID:28087327 
  17. Effects of Allergic Sensitization on Antiviral Immunity: Allergen, Virus, and Host Cell Mechanisms. Curr Allergy Asthma Rep. 2017;17(2):9. PMID:28233152 
  18. DNA Methylation Changes in Nasal Epithelia Are Associated with Allergic Asthma in the Inner City. Ann Am Thorac Soc. 2016;13 Suppl 1:S99-S100. PMCID:PMC5015744  PMID:27027970 
  19. Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses. J Immunol. 2016;196(5):2004-9. PMCID:PMC4761472  PMID:26826244 
  20. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136(6):1476-1485. PMCID:PMC4679705  PMID:26518090 
  21. DNA methylation and childhood asthma in the inner city. J Allergy Clin Immunol. 2015;136(1):69-80. PMCID:PMC4494877  PMID:25769910 
  22. Asthma: the interplay between viral infections and allergic diseases. Immunol Allergy Clin North Am. 2015;35(1):115-27. PMID:25459580 
  23. IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J Immunol. 2014;192(12):5687-94. PMCID:PMC4104489  PMID:24813204 
  24. Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents. J Allergy Clin Immunol Pract. 2013;1(2):163-71. PMCID:PMC4254887  PMID:24565455 
  25. IgE cross-linking critically impairs human monocyte function by blocking phagocytosis. J Allergy Clin Immunol. 2013;131(2):491-500.e1-5. PMCID:PMC3564054  PMID:23374271 
  26. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012;130(2):489-95. PMCID:PMC3437329  PMID:22766097 
  27. The role of dendritic cells in asthma. J Allergy Clin Immunol. 2012;129(4):889-901. PMID:22464668 
  28. Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol. 2010;185(2):813-7. PMCID:PMC2927323  PMID:20554961 
  29. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010;184(11):5999-6006. PMCID:PMC4820019  PMID:20410486 
  30. Motavizumab for the prevention of respiratory syncytial virus infection in infants. Expert Opin Biol Ther. 2009;9(10):1335-45. PMID:19764889 
  31. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis. 2008;198(11):1667-76. PMCID:PMC2696361  PMID:18847373 
  32. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med. 2008;168(16):1783-90. PMID:18779466 
  33. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol. 2008;180(10):6923-32. PMCID:PMC2387070  PMID:18453613 
  34. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008;82(1):335-45. PMCID:PMC2224404  PMID:17942531 
  35. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency. Ann Pharmacother. 2005;39(11):1861-9. PMID:16219903 
  36. Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection. Am J Health Syst Pharm. 2005;62(10):1073-4. PMID:15901593 
  37. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis. 2005;191(7):1105-15. PMID:15747246 
  38. Influence of seminal plasma PSP-I/PSP-II spermadhesin on pig gamete interaction. Zygote. 2005;13(1):11-6. PMID:15984156 
  39. Ultrasonic fetal size measurements in Brisbane, Australia. Australas Radiol. 2004;48(4):480-6. PMID:15601328 
  40. Stability of advanced life support drugs in the field. Am J Health Syst Pharm. 2004;61(6):597-602. PMID:15061431 
  41. Imipenem levels are not predictable in the critically ill patient. J Trauma. 2004;56(1):111-7. PMID:14749576 
  42. Pharmacokinetics of Ibuprofen in children with cystic fibrosis. Clin Pharmacokinet. 2004;43(3):145-56. PMID:14871154 
  43. Stability and antibacterial activity of cefepime during continuous infusion. Antimicrob Agents Chemother. 2003;47(6):1991-4. PMCID:PMC155835  PMID:12760882 
  44. A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther. 2003;25(6):1634-53. PMID:12860489 
  45. Visual compatibility of risperidone solution and lithium citrate syrup. Am J Health Syst Pharm. 2003;60(6):612-3. PMID:12659069 
  46. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol. 2002;63(12):1172-80. PMID:12480261 
  47. A wide interindividual variability of urinary 6beta-hydroxycortisol to free cortisol in 487 healthy Japanese subjects in near basal condition. Ther Drug Monit. 2002;24(6):722-7. PMID:12451288 
  48. Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease. Curr Opin Pulm Med. 2002;8(6):521-8. PMID:12394161 
  49. Evaluation of antibacterial activity of Bergenia ciliata. Pak J Pharm Sci. 2002;15(2):21-7. PMID:16414873 
  50. Development and implementation of an inpatient acute palliative care service. J Palliat Med. 2002;5(1):93-100. PMID:11839231 
  51. Bioactivity evaluation of Bergenia ciliata. Pak J Pharm Sci. 2002;15(1):15-33. PMID:16414865 
  52. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Antimicrob Agents Chemother. 2001;45(12):3468-73. PMCID:PMC90855  PMID:11709326 
  53. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol. 2001;167(4):2361-9. PMID:11490026 
  54. Citrobacter urinary tract infections in children. Pediatr Infect Dis J. 1999;18(10):889-92. PMID:10530585 
Last updated: 09/16/2021
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130